Opus Biotech Communications Adds New Clients
Web and social media expert, PJWCreative joins Opus as affiliate partner.
Seattle, WA , September 25, 2017– Opus Biotech Communications, a life sciences public affairs and investor relations consultancy based in Seattle, Atlanta and San Francisco, today announced the addition of two new clients: Cyrus Biotechnology and Lumen Bioscience, both based in Seattle. Opus Biotech also said PJW Creative, a web and social media firm, based in Orange County, CA has joined the company as an affiliate partner.
Cyrus Biotechnology has developed novel computational software which allows for the designing and modeling of new proteins and drugs on a computer. Lumen Bioscience has produced a new algae-based platform which can be used for industrial and drug products.
Opus Biotech’s other past and present clients include WuXi AppTec, bioNorthTX, Saranas, Cancer Prevention Pharmaceuticals, NanOlogy, BioVentures for Global Health, Kineta, KPI Therapeutics, GeoVax, Georgia Dental Hygienists’ Association, ApolloDX, CibusDX, and Impel Neuro Pharma.
Opus Biotech and their affiliate PJWCreative also recently built and launched new websites for Lumen BioScience, Nanology and Kineta. Through its affiliation with PJWCreative, Opus Biotech is able to provide clients with a range of marketing services, including brand identity, website design and maintenance, social media expertise, presentation design, and content marketing such as infographics, one-sheets and videos.
Opus Biotech was founded in October 2016 by Dan Eramian, former first Vice President of Communications for the Biotechnology Industry Organization (BIO) and EVP for Communications and Investor Relations at three biotech companies; and Charles Craig, a writer and editor for leading biotech publications and mainstream media organizations, and former President of Georgia Bio.
About Opus Biotech Communications Services
Opus Biotech Communications works with emerging life sciences companies to tell their stories of innovation, perseverance and value at affordable rates. We create strategies for connecting with industry news media, investors, business partners, opinion leaders, and patient groups. Our expertise is in the ability to develop clear, concise and compelling messages informed by extensive experience providing strategic planning in public and investor relations, development of CEO and company reputation management programs, website design, and bioethics consultation on organizational, research, marketing and clinical care issues. To learn more about Opus please visit our website: http://opusbiotech.com/.